TTBIO (6493)

TPEX

Currency in TWD

38.50

-8.80(-18.60%)

Closed·17/08

Fair Value

Unlock Value

Day's Range

38.50

48.70

52 wk Range

18.15

80.00

6493 Income Statement

Assess the TTBIO income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 6493 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

305.52

418.88

318.09

312.12

398.88

Total Revenues Growth

aa.aa

+70.72%

+37.11%

-24.06%

-1.88%

+27.8%

Cost Of Revenues

aa.aa

215.07

296.35

239.67

239.34

328.54

Gross Profit

aa.aa

90.45

122.53

78.42

72.77

70.34

Gross Profit Growth

aa.aa

+85.02%

+35.47%

-36%

-7.2%

-3.35%

Gross Profit Margin %

aa.aa

29.61%

29.25%

24.65%

23.32%

17.63%

Other Operating Expenses, Total

aa.aa

78.19

84.17

79.28

75.06

91.57

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+24.89%	+7.65%	-5.81%	-5.32%	+21.99%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	26.06	30.68	25.36	23.82	22.4
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	52.13	53.49	53.93	51.24	69.17
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

12.26

38.36

-0.86

-2.29

-21.23

Operating Income Growth

aa.aa

+189.33%

+212.92%

-102.25%

-165.43%

-827.93%

EBIT Margin %

aa.aa

4.01%

9.16%

-0.27%

-0.73%

-5.32%

Net Interest Expenses

aa.aa

-1.14

-1.45

-1.27

-4.19

-4.45

Net Interest Expenses Growth

aa.aa

+17.31%

-27.44%

+12.7%

-231.38%

-6.23%

Interest Expense, Total

aa.aa

-1.18

-1.58

-2.3

-4.93

-5.45

Interest And Investment Income

aa.aa

0.04

0.13

1.04

0.74

Other Non Operating Expenses, Total

aa.aa

2.93

11.1

10.22

9.82

4.56

EBT, Excl. Unusual Items

aa.aa

14.05

48.01

8.09

3.34

-21.13

Gain (Loss) On Sale Of Assets

aa.aa

0.07

0.3

0.06

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

14.12

48.31

8.09

3.4

-21.13

EBT, Incl. Unusual Items Growth

aa.aa

-69.31%

+242.12%

-83.26%

-57.99%

-721.81%

EBT, Incl. Unusual Items Margin

aa.aa

4.62%

11.53%

2.54%

1.09%

-5.3%

Income Tax Expense

aa.aa

2.59

8.51

1.41

0.81

0.17

Net Income to Company

aa.aa

11.53

39.8

6.68

2.59

-21.3

Minority Interest

aa.aa

Net Income

aa.aa

11.53

39.8

6.68

2.59

-21.3

Net Income Growth

aa.aa

-74.86%

+245.06%

-83.22%

-61.21%

-922.39%

Net Income Margin %

aa.aa

3.77%

9.5%

2.1%

0.83%

-5.34%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

11.53

39.8

6.68

2.59

-21.3

Basic EPS - Continuing Operations

aa.aa

0.48

1.65

0.28

0.11

-0.79

Basic EPS - Continuing Operations Growth

aa.aa

-74.86%

+245.06%

-83.22%

-61.21%

-832.76%

Diluted EPS - Continuing Operations

aa.aa

0.48

1.65

0.28

0.11

-0.79

Diluted EPS - Continuing Operations Growth

aa.aa

-74.76%

+244.08%

-83.17%

-61.21%

-833.57%

Basic Weighted Average Shares Outstanding

aa.aa

24.05

26.99

Diluted Weighted Average Shares Outstanding

aa.aa

24.07

24.09

24.07

24.06

26.99

Dividend Per Share

aa.aa

0.5

1.25

0.3

0.25

Dividend Per Share Growth

aa.aa

-75%

+150%

-76%

-16.67%

EBITDA

aa.aa

39.64

67.28

30.36

26.36

4.81

EBITDA Growth

aa.aa

+177.75%

+69.73%

-54.87%

-13.19%

-81.75%

EBITDA Margin %

aa.aa

12.97%

16.06%

9.54%

8.44%

1.21%

EBIT

aa.aa

12.26

38.36

-0.86

-2.29

-21.23

* In Millions of TWD (except for per share items)

FAQ

What was TTBIO’s revenue at year end?

At the end of the last reported fiscal year, TTBIO (6493) recorded total revenue of 398.88 million TWD.

What was TTBIO’s net income for the year?

For the full year, TTBIO reported net income of -21.30 million TWD.

What was TTBIO’s gross profit for the year?

Gross profit for the year was reported at 70.34 million TWD.

What was TTBIO’s annual operating income?

For the full year, TTBIO (6493) reported operating income of -21.23 million TWD.

S&P/TSX

36,667.92

-62.35

-0.17%

S&P/TSX 60

2,158.13

-6.10

-0.28%

US 30

53,507.60

+47.6

+0.09%

US 500

7,709.50

-35.9

-0.46%

S&P 500 VIX

15.94

+0.75

+4.94%

DAX

26,262.30

-107.36

-0.41%

Dollar Index

99.515

-0.019

-0.02%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	68.38	+2.97%	12.69M
RBC	300.09	-0.20%	2.23M
Enbridge	70.22	-0.55%	8.95M
Canadian Imperial Bank	171.36	-0.23%	2.89M
Shopify Inc	206.40	-3.71%	2.00M
Magna Intl	98.98	+1.46%	3.81M
Bank of Montreal	257.05	-0.32%	1.31M

Name	Last	Chg. %	Vol.
Asep Medical Holdings	0.39	+618.18%	3.00K
Asep Medical Holdings	0.39	+609.09%	3.00K
Metaguestai	0.03	+200.00%	93.75K
Metaguestai	0.03	+200.00%	93.75K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Psyched Wellness	0.01	+100.00%	7.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	131.80K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Iemr Resources	0.0050	-66.67%	2.00K
Evocati Capital Resources	0.03	-57.14%	1.00K
Nobel29 Resources	0.02	-50.00%	319.00K
Abacus Mining	0.02	-50.00%	23.86K
Martello Tech	0.0050	-50.00%	40.73K

Trending Stocks

Name	Last	Chg. %	Vol.
HIVE Digital Tech	4.2400	+13.98%	7.01M
Keel Infra	5.24	+7.60%	4.82M
Cenovus Energy Inc	44.56	+3.36%	4.34M
Canadian Natural	68.38	+2.97%	12.69M
Hut 8	122.010	+2.88%	293.89K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaa A	127.83	+52.56%	195.02
Aaaa Aaaaaa	1.5000	+50.18%	2.2527
A Aaa Aaaaaaaaaaaa	100.53	+47.84%	148.62
Aaaaaaaaaaaaaaaaaaa	9.11	+47.04%	13.40
Aaaaaa Aaaaa	16.57	+46.90%	24.34
Aa Aa Aaaaaaaaaa	30.49	+44.77%	44.14
Aaaaaa	33.23	+43.85%	47.80

Name	Last	Upside	Fair Value
A Aaa A	127.83	+52.56%	195.02
Aaaa Aaaaaa	1.5000	+50.18%	2.2527
A Aaa Aaaaaaaaaaaa	100.53	+47.84%	148.62
Aaaaaaaaaaaaaaaaaaa	9.11	+47.04%	13.40
Aaaaaa Aaaaa	16.57	+46.90%	24.34
Aa Aa Aaaaaaaaaa	30.49	+44.77%	44.14
Aaaaaa	33.23	+43.85%	47.80

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

TTBIO (6493)

6493 Income Statement

FAQ

What was TTBIO’s revenue at year end?

What was TTBIO’s net income for the year?

What was TTBIO’s gross profit for the year?

What was TTBIO’s annual operating income?

Trending Stocks